Selective Cell Death of Adrenocortical Cells by Pharmacological Activation of Mutant KCNJ5.

Authors: Mir-Bashiri S; Department of Medicine IV (S.M.-B., J.W., M.R., T.A.W.), Ludwig Maximilian University Hospital, Munich, Germany., Rakete S; Institute and Clinic for Occupational, Social and Environmental Medicine (S.R.), Ludwig Maximilian University Hospital, Munich, Germany., Wei J; Department of Medicine IV (S.M.-B., J.W., M.R., T.A.W.), Ludwig Maximilian University Hospital, Munich, Germany., Peitzsch M; Institute of Clinical Chemistry and Laboratory Medicine, University Hospital and Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Germany (M.P.)., Hahner S; Division of Endocrinology and Diabetes, Department of Medicine I, University Hospital Würzburg, Germany (S.H.)., Reincke M; Department of Medicine IV (S.M.-B., J.W., M.R., T.A.W.), Ludwig Maximilian University Hospital, Munich, Germany., Williams TA; Department of Medicine IV (S.M.-B., J.W., M.R., T.A.W.), Ludwig Maximilian University Hospital, Munich, Germany.

Source: Hypertension (Dallas, Tex. : 1979) [Hypertension] 2026 Oct; Vol. 83 (10), pp. e27181. Date of Electronic Publication: 2026 Aug 17.

Publication Type: Journal Article

Journal Info: Publisher: Lippincott, Williams & Wilkins Country of Publication: United States NLM ID: 7906255 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4563 (Electronic) Linking ISSN: 0194911X NLM ISO Abbreviation: Hypertension Subsets: MEDLINE

MeSH Terms: G Protein-Coupled Inwardly-Rectifying Potassium Channels*/genetics , G Protein-Coupled Inwardly-Rectifying Potassium Channels*/metabolism , G Protein-Coupled Inwardly-Rectifying Potassium Channels*/agonists , Adrenal Cortex*/drug effects , Adrenal Cortex*/metabolism , Adrenal Cortex*/pathology , Adrenal Cortex*/cytology , Cell Death*/drug effects , Cell Death*/genetics , Hyperaldosteronism*/genetics , Hyperaldosteronism*/metabolism , Hyperaldosteronism*/drug therapy , Hyperaldosteronism*/pathology , Mutation*, Cell Survival/drug effects ; Membrane Potentials/drug effects ; Sodium/metabolism ; Humans

Regression of Left Ventricular Hypertrophy in Primary Aldosteronism.

Authors: Goi J; Department of Endocrinology and Nutrition (J.G., M.A.-C.), Hospital Universitario Ramón y Cajal, Madrid, Spain., Burrello J; Division of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Torino, Italy (J.B., V.C., P.M.)., Schneider H; Division of Endocrinology, Department of Medicine IV (H.S., E.J.P., S.Z., M. Reincke), LMU University Hospital, Munich, Germany.; Division of Vascular Medicine, Department of Medicine IV (H.S.), LMU University Hospital, Munich, Germany., Petersenn EJ; Division of Endocrinology, Department of Medicine IV (H.S., E.J.P., S.Z., M. Reincke), LMU University Hospital, Munich, Germany., Zopp S; Division of Endocrinology, Department of Medicine IV (H.S., E.J.P., S.Z., M. Reincke), LMU University Hospital, Munich, Germany., Capuzzo V; Division of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Torino, Italy (J.B., V.C., P.M.)., García Cano AM; Department of Biochemistry (A.M.G.C., L.C.G.), Hospital Universitario Ramón y Cajal, Madrid, Spain., Caja Guayerbas L; Department of Biochemistry (A.M.G.C., L.C.G.), Hospital Universitario Ramón y Cajal, Madrid, Spain., Mena Ribas E; Department of Endocrinology and Nutrition, Hospital Universitario Son Espases, Palma, Islas Baleares, Spain (E.M.R., A.S.S.)., Sanmartín Sánchez A; Department of Endocrinology and Nutrition, Hospital Universitario Son Espases, Palma, Islas Baleares, Spain (E.M.R., A.S.S.)., Parra Ramírez P; Department of Endocrinology and Nutrition, Hospital Universitario La Paz, Madrid, Spain (P.P.R., P.M.R.-M.)., Martín Rojas-Marcos P; Department of Endocrinology and Nutrition, Hospital Universitario La Paz, Madrid, Spain (P.P.R., P.M.R.-M.)., Paja Fano M; Department of Endocrinology and Nutrition, OSI Bilbao-Basurto, Hospital Universitario de Basurto, Spain (M.P.F.).; University of the Basque Country UPV/EHU, Bilbao, Spain (M.P.F.)., Díaz Guardiola P; Department of Endocrinology and Nutrition, Hospital Universitario Infanta Sofía, Madrid, Spain (P.D.G.)., Rebollo Román Á; Department of Endocrinology and Nutrition, Hospital Universitario Reina Sofía, Córdoba, Spain (A.R.R.)., Moya Mateo EM; Department of Internal Medicine, Hospital Universitario Infanta Leonor, Madrid, Spain (E.M.M.M.)., Gabriel Ruiz-Sanchez J; Department of Endocrinology and Nutrition, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain (J.G.R.-S.)., González-Boillos M; Department of Endocrinology and Nutrition, Hospital Universitario de Castellón, Spain (M.G.-B.)., Jaén Aguila F; Department of Internal Medicine, Hospital Universitario Virgen de las Nieves, Granada, Spain (F.J.A.)., Perdomo CM; Department of Endocrinology and Nutrition, Clínica Universidad de Navarra, Pamplona, Spain (C.M.P.)., Robles Lázaro C; Department of Endocrinology and Nutrition, Hospital Clínico Universitario de Salamanca, Spain (C.R.L.)., Recasens M; Department of Endocrinology and Nutrition, Hospital de Girona Doctor Josep Trueta, Spain (M. Recasens, R.B.S.M.)., Barahona San Millan R; Department of Endocrinology and Nutrition, Hospital de Girona Doctor Josep Trueta, Spain (M. Recasens, R.B.S.M.)., Gómez-Hoyos E; Department of Endocrinology and Nutrition, Hospital Universitario de Valladolid, Spain (E.G.-H.)., Picón César MJ; Department of Endocrinology and Nutrition, Hospital Universitario Virgen de la Victoria de Málaga, IBIMA, Spain (M.J.P.C.)., Gutiérrez-Medina S; Department of Endocrinology and Nutrition, Clínica Universidad de Navarra, Madrid, Spain (S.G.-M.)., Lamas C; Department of Endocrinology and Nutrition, Hospital Universitario de Albacete, Spain (C.L.)., Casteras A; Department of Endocrinology and Nutrition, Hospital Universitario Val d'Hebron, Barcelona, Spain (A.C.)., Mulatero P; Division of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Torino, Italy (J.B., V.C., P.M.)., Reincke M; Division of Endocrinology, Department of Medicine IV (H.S., E.J.P., S.Z., M. Reincke), LMU University Hospital, Munich, Germany., Araujo-Castro M; Department of Endocrinology and Nutrition (J.G., M.A.-C.), Hospital Universitario Ramón y Cajal, Madrid, Spain.; Instituto de Investigación Biomédica Ramón y Cajal (IRYCIS), Madrid, Spain (M.A.-C.).

Corporate Authors: Adrenal Working Group of the Spanish Society of Endocrinology & Nutrition (SEEN)

Source: Hypertension (Dallas, Tex. : 1979) [Hypertension] 2026 Oct; Vol. 83 (10), pp. e26909. Date of Electronic Publication: 2026 Aug 17.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Lippincott, Williams & Wilkins Country of Publication: United States NLM ID: 7906255 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4563 (Electronic) Linking ISSN: 0194911X NLM ISO Abbreviation: Hypertension Subsets: MEDLINE

MeSH Terms: Adrenalectomy*/methods , Hyperaldosteronism*/complications , Hyperaldosteronism*/therapy , Hypertrophy, Left Ventricular*/diagnostic imaging , Hypertrophy, Left Ventricular*/epidemiology , Hypertrophy, Left Ventricular*/etiology , Hypertrophy, Left Ventricular*/therapy , Mineralocorticoid Receptor Antagonists*/therapeutic use, Aldosterone/blood ; Echocardiography/methods ; Europe/epidemiology ; Adult ; Female ; Humans ; Male ; Middle Aged ; Follow-Up Studies ; Prevalence ; Retrospective Studies ; Treatment Outcome ; Ventricular Remodeling ; Remission Induction

Assessment, External Verification and Modification of Models in Diagnosing Primary Aldosteronism Subtypes.

Authors: Jing Y; Department of Endocrinology, Xi'an No.3 Hospital, The Affiliated Hospital of Northwest University, Xi'an, China.; Department of Endocrinology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China., Zhang Y; Department of Endocrinology and Second Department of Geriatrics, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China., Guo H; Department of Endocrinology and Second Department of Geriatrics, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China., Hou R; Department of Endocrinology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China., Xu J; Department of Endocrinology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China., Wang J; Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China., Pan X; Xi'an Jiaotong University, Xi'an, China., Niu X; Xi'an Jiaotong University, Xi'an, China., Song L; Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China., Huang L; Department of Medical Ultrasound, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China., Zhang J; Xi'an Jiaotong University, Xi'an, China., Jia F; Department of Endocrinology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China., Sun B; Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China.; Postdoctoral Research Station, School of Nursing, Health Science Center, Xi'an Jiaotong University, Xi'an, China., Wang N; Department of Endocrinology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.; Postdoctoral Research Station, School of Nursing, Health Science Center, Xi'an Jiaotong University, Xi'an, China.

Source: Journal of clinical hypertension (Greenwich, Conn.) [J Clin Hypertens (Greenwich)] 2026 Sep; Vol. 28 (9), pp. e70340.

Publication Type: Journal Article

Journal Info: Publisher: Wiley Periodicals Inc Country of Publication: United States NLM ID: 100888554 Publication Model: Print Cited Medium: Internet ISSN: 1751-7176 (Electronic) Linking ISSN: 15246175 NLM ISO Abbreviation: J Clin Hypertens (Greenwich) Subsets: MEDLINE

MeSH Terms: Hyperaldosteronism*/diagnosis , Hyperaldosteronism*/classification , Hyperaldosteronism*/blood , Aldosterone*/blood, Humans ; Sensitivity and Specificity ; Reproducibility of Results

Primary Aldosteronism Medical Treatment Outcomes (PAMO) Beyond 12 Months.

Authors: Yang J; Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research, Clayton, Victoria, Australia (J.Y., R.L., P.J.F.).; Department of Medicine, Monash University, Clayton, Victoria, Australia (J.Y.)., Goi J; Division of Internal Medicine and Hypertension, Department of Medical Sciences, University of Torino, Italy (J.G., J.B., P.M.)., Burrello J; Division of Internal Medicine and Hypertension, Department of Medical Sciences, University of Torino, Italy (J.G., J.B., P.M.)., Reincke M; Department of Medicine IV, LMU University Hospital, Munich, Germany (M.R., C.A., D.B., T.A.W.)., Adolf C; Department of Medicine IV, LMU University Hospital, Munich, Germany (M.R., C.A., D.B., T.A.W.)., Brüdgam D; Department of Medicine IV, LMU University Hospital, Munich, Germany (M.R., C.A., D.B., T.A.W.)., Li Q; Department of Endocrinology, the First Affiliated Hospital of Chongqing Medical University, China (Q.L., Y.S., J.H., S.Y.)., Song Y; Department of Endocrinology, the First Affiliated Hospital of Chongqing Medical University, China (Q.L., Y.S., J.H., S.Y.)., Hu J; Department of Endocrinology, the First Affiliated Hospital of Chongqing Medical University, China (Q.L., Y.S., J.H., S.Y.)., Yang S; Department of Endocrinology, the First Affiliated Hospital of Chongqing Medical University, China (Q.L., Y.S., J.H., S.Y.)., Satoh F; Tohoku University Graduate School of Medicine, Sendai, Japan (F.S.)., Ono Y; Division of Nephrology, Rheumatology and Endocrinology, Tohoku University Graduate School of Medicine, Sendai, Japan (Y.O.)., Libianto R; Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research, Clayton, Victoria, Australia (J.Y., R.L., P.J.F.)., Stowasser M; Endocrine Hypertension Research Centre, University of Queensland, Frazer Institute, Princess Alexandra Hospital, Brisbane, Australia (M.S.)., Li N; Hypertension Center of People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China (N.L., Q.Z.)., Zhu Q; Hypertension Center of People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China (N.L., Q.Z.)., Hong N; Division of Endocrinology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea (N.H.)., Nayak D; Metro South Health (Princess Alexandra Hospital), Woolloongabba, Queensland, Australia (D.N.)., Puar TH; Department of Endocrinology, Changi General Hospital, SingHealth, Singapore (T.H.P.)., Wu VC; Nephrology Division, Primary Aldosterone Center, Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan (V.-C.W.)., Vaidya A; Center for Adrenal Disorders, Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (A.V.)., Araujo-Castro M; Endocrinology & Nutrition Department, Ramón y Cajal Hospital, Madrid, Spain (M.A.-C.)., Kocjan T; Department of Endocrinology, Diabetes, and Metabolic Diseases, University Medical Centre Ljubljana, Slovenia (T.K.).; Faculty of Medicine, University of Ljubljana, Slovenia (T.K.)., O'Toole SM; Department of Endocrinology, Royal Hallamshire Hospital, Sheffield, United Kingdom (S.M.O.T.)., Hundemer GL; Division of Nephrology, Department of Medicine, University of Ottawa, ON, Canada (G.L.H.)., Ragnarsson O; Wallenberg Center for Molecular and Translational Medicine, University of Gothenburg, Sweden (O.R.)., Lacroix A; Centre hospitalier de l'Université de Montréal (CHUM), Canada (A.L., S.L.)., Larose S; Centre hospitalier de l'Université de Montréal (CHUM), Canada (A.L., S.L.)., Nakai K; Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Kanagawa, Japan (K.N., T.N.)., Nishikawa T; Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Kanagawa, Japan (K.N., T.N.)., Ladygina D; Federal State Autonomous Educational Institution of Higher Education I.M.Sechenov, Moscow, Russia (D.L.)., Turcu AF; Division of Metabolism, Endocrinology, and Diabetes, University of Michigan, Ann Arbor (A.F.T., P.V.)., Vibhatavata P; Division of Metabolism, Endocrinology, and Diabetes, University of Michigan, Ann Arbor (A.F.T., P.V.)., Fardella CE; Centro Traslacional de Endocrinologia Universidad Catolica de Chile (CETREN-UC), Santiago, Chile (C.E.F., T.U.)., Uslar T; Centro Traslacional de Endocrinologia Universidad Catolica de Chile (CETREN-UC), Santiago, Chile (C.E.F., T.U.)., Quinkler M; Endocrinology in Charlottenburg, Berlin, Germany (M.Q.)., Mulatero P; Division of Internal Medicine and Hypertension, Department of Medical Sciences, University of Torino, Italy (J.G., J.B., P.M.)., Pintus G; Department of Medicine DIMED, Specialized Center for Blood Pressure Disorders-Regione Veneto, University of Padua, Italy (G.P., G.P.R.)., Rossi GP; Department of Medicine DIMED, Specialized Center for Blood Pressure Disorders-Regione Veneto, University of Padua, Italy (G.P., G.P.R.)., Hahner S; Division of Endocrinology and Diabetes, Department of Internal Medicine I, University Hospital Würzburg, Germany (S.H.)., Amar L; Paris City University, Hypertension Unit, Adrenal Referral Center, Paris, France (L.A.)., Drake WM; Department of Endocrinology, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom (W.M.D., C.V.)., Varsani C; Department of Endocrinology, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom (W.M.D., C.V.)., Brown MJ; Endocrine Hypertension, Department of Clinical Pharmacology and Precision Medicine, William Harvey Research Institute, Queen Mary University of London, United Kingdom (M.J.B., X.W.)., Wu X; Endocrine Hypertension, Department of Clinical Pharmacology and Precision Medicine, William Harvey Research Institute, Queen Mary University of London, United Kingdom (M.J.B., X.W.)., Young WF Jr; Department of Internal Medicine, Mayo Clinic, Rochester, MN (W.F.Y.)., Williams TA; Department of Medicine IV, LMU University Hospital, Munich, Germany (M.R., C.A., D.B., T.A.W.)., Fuller PJ; Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research, Clayton, Victoria, Australia (J.Y., R.L., P.J.F.).; Department of Endocrinology, Monash Health, Victoria, Australia (P.J.F.).

Source: Hypertension (Dallas, Tex. : 1979) [Hypertension] 2026 Sep; Vol. 83 (9), pp. e27431. Date of Electronic Publication: 2026 Jul 22.

Publication Type: Journal Article; Multicenter Study; Observational Study

Journal Info: Publisher: Lippincott, Williams & Wilkins Country of Publication: United States NLM ID: 7906255 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4563 (Electronic) Linking ISSN: 0194911X NLM ISO Abbreviation: Hypertension Subsets: MEDLINE

MeSH Terms: Hyperaldosteronism*/drug therapy , Hyperaldosteronism*/complications , Hyperaldosteronism*/blood , Mineralocorticoid Receptor Antagonists*/therapeutic use , Hypertension*/etiology , Hypertension*/drug therapy, Aldosterone/blood ; Humans ; Female ; Male ; Middle Aged ; Treatment Outcome ; Follow-Up Studies ; Time Factors ; Adult

Resistant Hypertension Variants Link to Hyperaldosteronism and Potassium Levels.

Authors: Tragante V; Amgen deCODE genetics, Reykjavik, Iceland (V.T., P.S., G. Thorleifsson, M.L.F., A.M.D., E.F., S.G., G.H.H., A.H., I.J., R.P.K., A.E.L., S.H.L., M.I.M., P.M., A.O., L.S., D.O.A., G.S., G.M., G. Thorgeirsson, U.T., D.F.G., K.S., H.H.).; Division Heart and Lungs, Department of Cardiology, UMC Utrecht, University of Utrecht, the Netherlands (V.T.)., Sulem P; Amgen deCODE genetics, Reykjavik, Iceland (V.T., P.S., G. Thorleifsson, M.L.F., A.M.D., E.F., S.G., G.H.H., A.H., I.J., R.P.K., A.E.L., S.H.L., M.I.M., P.M., A.O., L.S., D.O.A., G.S., G.M., G. Thorgeirsson, U.T., D.F.G., K.S., H.H.)., Thorleifsson G; Amgen deCODE genetics, Reykjavik, Iceland (V.T., P.S., G. Thorleifsson, M.L.F., A.M.D., E.F., S.G., G.H.H., A.H., I.J., R.P.K., A.E.L., S.H.L., M.I.M., P.M., A.O., L.S., D.O.A., G.S., G.M., G. Thorgeirsson, U.T., D.F.G., K.S., H.H.)., Frigge ML; Amgen deCODE genetics, Reykjavik, Iceland (V.T., P.S., G. Thorleifsson, M.L.F., A.M.D., E.F., S.G., G.H.H., A.H., I.J., R.P.K., A.E.L., S.H.L., M.I.M., P.M., A.O., L.S., D.O.A., G.S., G.M., G. Thorgeirsson, U.T., D.F.G., K.S., H.H.)., Arthur JG; 10x Genomics, Inc., Pleasanton, CA (J.G.A.)., Asselbergs FW; Amsterdam University Medical Centers, Department of Cardiology, University of Amsterdam, the Netherlands (F.W.A.).; Health Data Research UK and Institute of Health Informatics, University College London, United Kingdom (F.W.A.)., Banasik K; Department of Obstetrics and Gynaecology, Copenhagen University Hospital Hvidovre, Denmark (K.B.).; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences (K.B., S.B.), University of Copenhagen, Denmark., Brunak S; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences (K.B., S.B.), University of Copenhagen, Denmark., Christensen AH; Department of Clinical Medicine, Faculty of Health and Medical Sciences (A.H.C., K.K.I., S.R.O., O.B.P., H.B.), University of Copenhagen, Denmark.; Department of Cardiology, Herlev-Gentofte Hospital, Copenhagen University Hospital, Denmark (A.H.C., K.K.I.)., Crawford DC; Department of Population and Quantitative Health Sciences (D.C.C.), Case Western Reserve University, Cleveland, OH.; Cleveland Institute for Computational Biology (D.C.C.), Case Western Reserve University, Cleveland, OH.; Department of Genetics and Genome Sciences (D.C.C.), Case Western Reserve University, Cleveland, OH., Deaton AM; Amgen deCODE genetics, Reykjavik, Iceland (V.T., P.S., G. Thorleifsson, M.L.F., A.M.D., E.F., S.G., G.H.H., A.H., I.J., R.P.K., A.E.L., S.H.L., M.I.M., P.M., A.O., L.S., D.O.A., G.S., G.M., G. Thorgeirsson, U.T., D.F.G., K.S., H.H.)., Erikstrup C; Department of Clinical Immunology, Aarhus University Hospital, Denmark (C.E.).; Department of Clinical Medicine, Health, Aarhus University, Denmark (C.E.)., Ferkingstad E; Amgen deCODE genetics, Reykjavik, Iceland (V.T., P.S., G. Thorleifsson, M.L.F., A.M.D., E.F., S.G., G.H.H., A.H., I.J., R.P.K., A.E.L., S.H.L., M.I.M., P.M., A.O., L.S., D.O.A., G.S., G.M., G. Thorgeirsson, U.T., D.F.G., K.S., H.H.)., Ghouse J; Department of Cardiology, The Heart Center, Rigshospitalet, Copenhagen University Hospital, Denmark (J.G., H.B.)., Gretarsdottir S; Amgen deCODE genetics, Reykjavik, Iceland (V.T., P.S., G. Thorleifsson, M.L.F., A.M.D., E.F., S.G., G.H.H., A.H., I.J., R.P.K., A.E.L., S.H.L., M.I.M., P.M., A.O., L.S., D.O.A., G.S., G.M., G. Thorgeirsson, U.T., D.F.G., K.S., H.H.)., Halldorsson GH; Amgen deCODE genetics, Reykjavik, Iceland (V.T., P.S., G. Thorleifsson, M.L.F., A.M.D., E.F., S.G., G.H.H., A.H., I.J., R.P.K., A.E.L., S.H.L., M.I.M., P.M., A.O., L.S., D.O.A., G.S., G.M., G. Thorgeirsson, U.T., D.F.G., K.S., H.H.).; School of Engineering and Natural Sciences (G.H.H., S.H.L., P.M., D.F.G.), University of Iceland, Reykjavik., Helgadottir A; Amgen deCODE genetics, Reykjavik, Iceland (V.T., P.S., G. Thorleifsson, M.L.F., A.M.D., E.F., S.G., G.H.H., A.H., I.J., R.P.K., A.E.L., S.H.L., M.I.M., P.M., A.O., L.S., D.O.A., G.S., G.M., G. Thorgeirsson, U.T., D.F.G., K.S., H.H.)., Iversen KK; Department of Clinical Medicine, Faculty of Health and Medical Sciences (A.H.C., K.K.I., S.R.O., O.B.P., H.B.), University of Copenhagen, Denmark.; Department of Cardiology, Herlev-Gentofte Hospital, Copenhagen University Hospital, Denmark (A.H.C., K.K.I.)., Jonsdottir I; Amgen deCODE genetics, Reykjavik, Iceland (V.T., P.S., G. Thorleifsson, M.L.F., A.M.D., E.F., S.G., G.H.H., A.H., I.J., R.P.K., A.E.L., S.H.L., M.I.M., P.M., A.O., L.S., D.O.A., G.S., G.M., G. Thorgeirsson, U.T., D.F.G., K.S., H.H.).; Faculty of Medicine, School of Health Sciences (I.J., R.P., D.O.A., G. Thorgeirsson, L.D.N., U.T., K.S.), University of Iceland, Reykjavik., Knowlton KU; Intermountain Medical Center, Intermountain Heart Institute, Salt Lake City, UT (K.U.K.).; University of Utah, School of Medicine, Salt Lake City (K.U.K.)., Kristjansson RP; Amgen deCODE genetics, Reykjavik, Iceland (V.T., P.S., G. Thorleifsson, M.L.F., A.M.D., E.F., S.G., G.H.H., A.H., I.J., R.P.K., A.E.L., S.H.L., M.I.M., P.M., A.O., L.S., D.O.A., G.S., G.M., G. Thorgeirsson, U.T., D.F.G., K.S., H.H.)., Larusdottir AE; Amgen deCODE genetics, Reykjavik, Iceland (V.T., P.S., G. Thorleifsson, M.L.F., A.M.D., E.F., S.G., G.H.H., A.H., I.J., R.P.K., A.E.L., S.H.L., M.I.M., P.M., A.O., L.S., D.O.A., G.S., G.M., G. Thorgeirsson, U.T., D.F.G., K.S., H.H.)., Lund SH; Amgen deCODE genetics, Reykjavik, Iceland (V.T., P.S., G. Thorleifsson, M.L.F., A.M.D., E.F., S.G., G.H.H., A.H., I.J., R.P.K., A.E.L., S.H.L., M.I.M., P.M., A.O., L.S., D.O.A., G.S., G.M., G. Thorgeirsson, U.T., D.F.G., K.S., H.H.).; School of Engineering and Natural Sciences (G.H.H., S.H.L., P.M., D.F.G.), University of Iceland, Reykjavik., Magnusson MI; Amgen deCODE genetics, Reykjavik, Iceland (V.T., P.S., G. Thorleifsson, M.L.F., A.M.D., E.F., S.G., G.H.H., A.H., I.J., R.P.K., A.E.L., S.H.L., M.I.M., P.M., A.O., L.S., D.O.A., G.S., G.M., G. Thorgeirsson, U.T., D.F.G., K.S., H.H.)., Melsted P; Amgen deCODE genetics, Reykjavik, Iceland (V.T., P.S., G. Thorleifsson, M.L.F., A.M.D., E.F., S.G., G.H.H., A.H., I.J., R.P.K., A.E.L., S.H.L., M.I.M., P.M., A.O., L.S., D.O.A., G.S., G.M., G. Thorgeirsson, U.T., D.F.G., K.S., H.H.).; School of Engineering and Natural Sciences (G.H.H., S.H.L., P.M., D.F.G.), University of Iceland, Reykjavik., Nyegaard M; Department of Health Science and Technology, Faculty of Medicine, Aalborg University, Denmark (M.N.)., Oddsson A; Amgen deCODE genetics, Reykjavik, Iceland (V.T., P.S., G. Thorleifsson, M.L.F., A.M.D., E.F., S.G., G.H.H., A.H., I.J., R.P.K., A.E.L., S.H.L., M.I.M., P.M., A.O., L.S., D.O.A., G.S., G.M., G. Thorgeirsson, U.T., D.F.G., K.S., H.H.)., Olafsson I; Clinical Biochemistry, Clinical Laboratory Services (I.O.), Landspitali University Hospital, Reykjavik, Iceland., Olesen MS; Laboratory of Molecular Cardiology, Department of Cardiology, The Heart Centre (M.S.O.), Copenhagen University Hospital, Rigshospitalet, Denmark., Ostrowski SR; Department of Clinical Medicine, Faculty of Health and Medical Sciences (A.H.C., K.K.I., S.R.O., O.B.P., H.B.), University of Copenhagen, Denmark.; Department of Clinical Immunology (S.R.O.), Copenhagen University Hospital, Rigshospitalet, Denmark., Palsson R; Faculty of Medicine, School of Health Sciences (I.J., R.P., D.O.A., G. Thorgeirsson, L.D.N., U.T., K.S.), University of Iceland, Reykjavik.; Section of Nephrology, Internal Medicine Services (R.P.), Landspitali University Hospital, Reykjavik, Iceland., Pedersen OB; Department of Clinical Medicine, Faculty of Health and Medical Sciences (A.H.C., K.K.I., S.R.O., O.B.P., H.B.), University of Copenhagen, Denmark.; Department of Clinical Immunology, Zealand University Hospital, Køge, Denmark (O.B.P.)., Sigurdardottir O; Department of Clinical Biochemistry, Akureyri Hospital (O.S.)., Stefansdottir L; Amgen deCODE genetics, Reykjavik, Iceland (V.T., P.S., G. Thorleifsson, M.L.F., A.M.D., E.F., S.G., G.H.H., A.H., I.J., R.P.K., A.E.L., S.H.L., M.I.M., P.M., A.O., L.S., D.O.A., G.S., G.M., G. Thorgeirsson, U.T., D.F.G., K.S., H.H.)., Arnar DO; Amgen deCODE genetics, Reykjavik, Iceland (V.T., P.S., G. Thorleifsson, M.L.F., A.M.D., E.F., S.G., G.H.H., A.H., I.J., R.P.K., A.E.L., S.H.L., M.I.M., P.M., A.O., L.S., D.O.A., G.S., G.M., G. Thorgeirsson, U.T., D.F.G., K.S., H.H.).; Faculty of Medicine, School of Health Sciences (I.J., R.P., D.O.A., G. Thorgeirsson, L.D.N., U.T., K.S.), University of Iceland, Reykjavik.; Section of Cardiology, Cardiovascular Services (D.O.A.), Landspitali University Hospital, Reykjavik, Iceland., Sveinbjornsson G; Amgen deCODE genetics, Reykjavik, Iceland (V.T., P.S., G. Thorleifsson, M.L.F., A.M.D., E.F., S.G., G.H.H., A.H., I.J., R.P.K., A.E.L., S.H.L., M.I.M., P.M., A.O., L.S., D.O.A., G.S., G.M., G. Thorgeirsson, U.T., D.F.G., K.S., H.H.)., Masson G; Amgen deCODE genetics, Reykjavik, Iceland (V.T., P.S., G. Thorleifsson, M.L.F., A.M.D., E.F., S.G., G.H.H., A.H., I.J., R.P.K., A.E.L., S.H.L., M.I.M., P.M., A.O., L.S., D.O.A., G.S., G.M., G. Thorgeirsson, U.T., D.F.G., K.S., H.H.)., Sigurdsson EL; Department of Family Medicine (E.L.S.), University of Iceland, Reykjavik.; Development Centre for Primary Health Care in Iceland, Reykjavik, Iceland (E.L.S.)., Thorgeirsson G; Amgen deCODE genetics, Reykjavik, Iceland (V.T., P.S., G. Thorleifsson, M.L.F., A.M.D., E.F., S.G., G.H.H., A.H., I.J., R.P.K., A.E.L., S.H.L., M.I.M., P.M., A.O., L.S., D.O.A., G.S., G.M., G. Thorgeirsson, U.T., D.F.G., K.S., H.H.).; Faculty of Medicine, School of Health Sciences (I.J., R.P., D.O.A., G. Thorgeirsson, L.D.N., U.T., K.S.), University of Iceland, Reykjavik., Ullum H; Statens Serum Institut, Copenhagen, Denmark (H.U.)., Nadauld LD; Faculty of Medicine, School of Health Sciences (I.J., R.P., D.O.A., G. Thorgeirsson, L.D.N., U.T., K.S.), University of Iceland, Reykjavik., Thorsteinsdottir U; Amgen deCODE genetics, Reykjavik, Iceland (V.T., P.S., G. Thorleifsson, M.L.F., A.M.D., E.F., S.G., G.H.H., A.H., I.J., R.P.K., A.E.L., S.H.L., M.I.M., P.M., A.O., L.S., D.O.A., G.S., G.M., G. Thorgeirsson, U.T., D.F.G., K.S., H.H.).; Faculty of Medicine, School of Health Sciences (I.J., R.P., D.O.A., G. Thorgeirsson, L.D.N., U.T., K.S.), University of Iceland, Reykjavik., Bundgaard H; Department of Clinical Medicine, Faculty of Health and Medical Sciences (A.H.C., K.K.I., S.R.O., O.B.P., H.B.), University of Copenhagen, Denmark.; Department of Cardiology, The Heart Center, Rigshospitalet, Copenhagen University Hospital, Denmark (J.G., H.B.)., Gudbjartsson DF; Amgen deCODE genetics, Reykjavik, Iceland (V.T., P.S., G. Thorleifsson, M.L.F., A.M.D., E.F., S.G., G.H.H., A.H., I.J., R.P.K., A.E.L., S.H.L., M.I.M., P.M., A.O., L.S., D.O.A., G.S., G.M., G. Thorgeirsson, U.T., D.F.G., K.S., H.H.).; School of Engineering and Natural Sciences (G.H.H., S.H.L., P.M., D.F.G.), University of Iceland, Reykjavik., Stefansson K; Amgen deCODE genetics, Reykjavik, Iceland (V.T., P.S., G. Thorleifsson, M.L.F., A.M.D., E.F., S.G., G.H.H., A.H., I.J., R.P.K., A.E.L., S.H.L., M.I.M., P.M., A.O., L.S., D.O.A., G.S., G.M., G. Thorgeirsson, U.T., D.F.G., K.S., H.H.).; Faculty of Medicine, School of Health Sciences (I.J., R.P., D.O.A., G. Thorgeirsson, L.D.N., U.T., K.S.), University of Iceland, Reykjavik., Holm H; Amgen deCODE genetics, Reykjavik, Iceland (V.T., P.S., G. Thorleifsson, M.L.F., A.M.D., E.F., S.G., G.H.H., A.H., I.J., R.P.K., A.E.L., S.H.L., M.I.M., P.M., A.O., L.S., D.O.A., G.S., G.M., G. Thorgeirsson, U.T., D.F.G., K.S., H.H.).

Corporate Authors: DBDS Genomic Consortium

Source: Hypertension (Dallas, Tex. : 1979) [Hypertension] 2026 Sep; Vol. 83 (9), pp. e22301. Date of Electronic Publication: 2026 Jul 09.

Publication Type: Journal Article

Journal Info: Publisher: Lippincott, Williams & Wilkins Country of Publication: United States NLM ID: 7906255 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4563 (Electronic) Linking ISSN: 0194911X NLM ISO Abbreviation: Hypertension Subsets: MEDLINE

MeSH Terms: Hyperaldosteronism*/genetics , Hyperaldosteronism*/blood , Hypertension*/drug therapy , Hypertension*/genetics , Hypertension*/blood , Hypertension*/physiopathology , Potassium*/blood , Antihypertensive Agents*/therapeutic use , Blood Pressure*/drug effects , Blood Pressure*/genetics , Blood Pressure*/physiology , Drug Resistance*/genetics, Genome-Wide Association Study/methods ; Humans ; Female ; Male ; Middle Aged ; Iceland ; Polymorphism, Single Nucleotide

Genetics and Primary Aldosteronism: Disease Phenotype and Demographic Implications for Hypertension.

Authors: Fayad M; Université Paris Cité, PARCC, Inserm, France (M.F., D.I., S.B., F.L.F.-R., M.-C.Z.)., Ismail D; Université Paris Cité, PARCC, Inserm, France (M.F., D.I., S.B., F.L.F.-R., M.-C.Z.)., Boulkroun S; Université Paris Cité, PARCC, Inserm, France (M.F., D.I., S.B., F.L.F.-R., M.-C.Z.)., Fernandes-Rosa FL; Université Paris Cité, PARCC, Inserm, France (M.F., D.I., S.B., F.L.F.-R., M.-C.Z.)., Zennaro MC; Université Paris Cité, PARCC, Inserm, France (M.F., D.I., S.B., F.L.F.-R., M.-C.Z.).; Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Service de Génétique, France (M.-C.Z.).

Source: Hypertension (Dallas, Tex. : 1979) [Hypertension] 2026 Aug; Vol. 83 (8), pp. e26232. Date of Electronic Publication: 2026 Jun 03.

Publication Type: Journal Article; Review

Journal Info: Publisher: Lippincott, Williams & Wilkins Country of Publication: United States NLM ID: 7906255 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4563 (Electronic) Linking ISSN: 0194911X NLM ISO Abbreviation: Hypertension Subsets: MEDLINE

MeSH Terms: Hyperaldosteronism*/genetics , Hyperaldosteronism*/epidemiology , Hyperaldosteronism*/complications , Hyperaldosteronism*/physiopathology , Hypertension*/genetics , Hypertension*/epidemiology , Hypertension*/etiology , Hypertension*/physiopathology, Aldosterone/metabolism ; Humans ; Phenotype ; Genetic Predisposition to Disease ; Prevalence

A Rare Presentation of Chronic Nonsteroidal Anti-inflammatory Drug-induced Acute-on-chronic Kidney Disease with Secondary Hyperaldosteronism and Hyperparathyroidism in a Young Male with Refractory Hypertension.

Authors: Diggikar PM; Department of Internal Medicine, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pune, Maharashtra, India., Janani R, Jagirdar A, Shah KU

Source: Annals of African medicine [Ann Afr Med] 2026 Aug 01; Vol. 25 (Suppl 1), pp. S103-S106. Date of Electronic Publication: 2026 Jan 23.

Publication Type: Journal Article; Case Reports

Journal Info: Publisher: Medknow Publications Country of Publication: India NLM ID: 101231417 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 0975-5764 (Electronic) Linking ISSN: 09755764 NLM ISO Abbreviation: Ann Afr Med Subsets: MEDLINE

MeSH Terms: Hypertension*/drug therapy , Hypertension*/complications , Anti-Inflammatory Agents, Non-Steroidal*/adverse effects , Hyperaldosteronism*/chemically induced , Hyperaldosteronism*/diagnosis , Hyperparathyroidism, Secondary*/chemically induced , Hyperparathyroidism, Secondary*/diagnosis, Humans ; Male ; Adult ; Hypokalemia

[Stratified and graded diagnosis and treatment strategies for patients with primary aldosteronism].

Authors: Wang XJ; Department of Endocrinology, the First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510080, China., Cao XP; Department of Endocrinology, the First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510080, China.

Source: Zhonghua yi xue za zhi [Zhonghua Yi Xue Za Zhi] 2026 Oct 13; Vol. 106 (37), pp. 3934-3938.

Publication Type: English Abstract; Journal Article

Journal Info: Publisher: Zhonghua yi xue hui Country of Publication: China NLM ID: 7511141 Publication Model: Print Cited Medium: Print ISSN: 0376-2491 (Print) Linking ISSN: 03762491 NLM ISO Abbreviation: Zhonghua Yi Xue Za Zhi Subsets: MEDLINE

MeSH Terms: Hyperaldosteronism*/diagnosis , Hyperaldosteronism*/therapy , Hyperaldosteronism*/classification, Humans

Optimizing adrenal vein sampling interpretation for primary aldosteronism subtyping.

Authors: Xiong Y; Department of Endocrinology, Sichuan-Chongqing Joint Key Laboratory of Metabolic Vascular Diseases, Chongqing Key Laboratory of Translational Medicine in Major Metabolic Diseases, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi Road, Yuzhong District, Chongqing, 400016, China., Luo S; Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China., Peng S; Department of Endocrinology, Sichuan-Chongqing Joint Key Laboratory of Metabolic Vascular Diseases, Chongqing Key Laboratory of Translational Medicine in Major Metabolic Diseases, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi Road, Yuzhong District, Chongqing, 400016, China., Jing Y; Department of Endocrinology, Sichuan-Chongqing Joint Key Laboratory of Metabolic Vascular Diseases, Chongqing Key Laboratory of Translational Medicine in Major Metabolic Diseases, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi Road, Yuzhong District, Chongqing, 400016, China., Shen H; Department of Endocrinology, Sichuan-Chongqing Joint Key Laboratory of Metabolic Vascular Diseases, Chongqing Key Laboratory of Translational Medicine in Major Metabolic Diseases, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi Road, Yuzhong District, Chongqing, 400016, China., Zhang X; Department of Endocrinology, Sichuan-Chongqing Joint Key Laboratory of Metabolic Vascular Diseases, Chongqing Key Laboratory of Translational Medicine in Major Metabolic Diseases, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi Road, Yuzhong District, Chongqing, 400016, China., Zeng Q; Department of Endocrinology, Sichuan-Chongqing Joint Key Laboratory of Metabolic Vascular Diseases, Chongqing Key Laboratory of Translational Medicine in Major Metabolic Diseases, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi Road, Yuzhong District, Chongqing, 400016, China., Song Y; Department of Endocrinology, Sichuan-Chongqing Joint Key Laboratory of Metabolic Vascular Diseases, Chongqing Key Laboratory of Translational Medicine in Major Metabolic Diseases, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi Road, Yuzhong District, Chongqing, 400016, China., Zhen Q; Department of Endocrinology, Sichuan-Chongqing Joint Key Laboratory of Metabolic Vascular Diseases, Chongqing Key Laboratory of Translational Medicine in Major Metabolic Diseases, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi Road, Yuzhong District, Chongqing, 400016, China., He Y; Department of Endocrinology, Sichuan-Chongqing Joint Key Laboratory of Metabolic Vascular Diseases, Chongqing Key Laboratory of Translational Medicine in Major Metabolic Diseases, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi Road, Yuzhong District, Chongqing, 400016, China., He W; Department of Endocrinology, Sichuan-Chongqing Joint Key Laboratory of Metabolic Vascular Diseases, Chongqing Key Laboratory of Translational Medicine in Major Metabolic Diseases, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi Road, Yuzhong District, Chongqing, 400016, China., Zhang Q; Department of Endocrinology, Sichuan-Chongqing Joint Key Laboratory of Metabolic Vascular Diseases, Chongqing Key Laboratory of Translational Medicine in Major Metabolic Diseases, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi Road, Yuzhong District, Chongqing, 400016, China., Hu J; Department of Endocrinology, Sichuan-Chongqing Joint Key Laboratory of Metabolic Vascular Diseases, Chongqing Key Laboratory of Translational Medicine in Major Metabolic Diseases, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi Road, Yuzhong District, Chongqing, 400016, China., Ma L; Department of Endocrinology, Sichuan-Chongqing Joint Key Laboratory of Metabolic Vascular Diseases, Chongqing Key Laboratory of Translational Medicine in Major Metabolic Diseases, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi Road, Yuzhong District, Chongqing, 400016, China., Li Q; Department of Endocrinology, Sichuan-Chongqing Joint Key Laboratory of Metabolic Vascular Diseases, Chongqing Key Laboratory of Translational Medicine in Major Metabolic Diseases, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi Road, Yuzhong District, Chongqing, 400016, China., Yang S; Department of Endocrinology, Sichuan-Chongqing Joint Key Laboratory of Metabolic Vascular Diseases, Chongqing Key Laboratory of Translational Medicine in Major Metabolic Diseases, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi Road, Yuzhong District, Chongqing, 400016, China. 203737@hospital.cqmu.edu.cn.

Corporate Authors: Chongqing Primary Aldosteronism Study (CONPASS) Group

Source: Endocrine [Endocrine] 2026 Oct 06; Vol. 91 (1). Date of Electronic Publication: 2026 Oct 06.

Publication Type: Journal Article

Journal Info: Publisher: Humana Press Country of Publication: United States NLM ID: 9434444 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-0100 (Electronic) Linking ISSN: 1355008X NLM ISO Abbreviation: Endocrine Subsets: MEDLINE

MeSH Terms: Hyperaldosteronism*/blood , Hyperaldosteronism*/diagnosis , Hyperaldosteronism*/classification , Adrenal Glands*/blood supply , Blood Specimen Collection*/methods, Aldosterone/blood ; Hydrocortisone/blood ; Humans ; Female ; Retrospective Studies ; Male ; Middle Aged ; Veins ; Adult ; Aged

Dexamethasone Nonsuppression in Primary Aldosteronism: Associations With Adrenal Imaging Findings.

Authors: Zhang XT; Department of Cardiovascular Medicine The 2nd Affiliated Hospital, Jiangxi Medical College, Nanchang University Nanchang Jiangxi China.; Molecular Medicine of Jiangxi Key Laboratory The Second Affiliated Hospital of Nanchang University Nanchang Jiangxi 330006 China., Zeng QT; Department of Cardiovascular Medicine The 2nd Affiliated Hospital, Jiangxi Medical College, Nanchang University Nanchang Jiangxi China.; Molecular Medicine of Jiangxi Key Laboratory The Second Affiliated Hospital of Nanchang University Nanchang Jiangxi 330006 China., Lin ZX; Department of Cardiovascular Medicine The 2nd Affiliated Hospital, Jiangxi Medical College, Nanchang University Nanchang Jiangxi China.; Molecular Medicine of Jiangxi Key Laboratory The Second Affiliated Hospital of Nanchang University Nanchang Jiangxi 330006 China., Zhang HJ; Department of Cardiovascular Medicine The 2nd Affiliated Hospital, Jiangxi Medical College, Nanchang University Nanchang Jiangxi China.; Molecular Medicine of Jiangxi Key Laboratory The Second Affiliated Hospital of Nanchang University Nanchang Jiangxi 330006 China., Wu MB; Department of Cardiovascular Medicine The 2nd Affiliated Hospital, Jiangxi Medical College, Nanchang University Nanchang Jiangxi China.; Molecular Medicine of Jiangxi Key Laboratory The Second Affiliated Hospital of Nanchang University Nanchang Jiangxi 330006 China., Zhang H; Department of Cardiovascular Medicine The 2nd Affiliated Hospital, Jiangxi Medical College, Nanchang University Nanchang Jiangxi China.; Molecular Medicine of Jiangxi Key Laboratory The Second Affiliated Hospital of Nanchang University Nanchang Jiangxi 330006 China., Wang R; Department of Cardiovascular Medicine The 2nd Affiliated Hospital, Jiangxi Medical College, Nanchang University Nanchang Jiangxi China.; Molecular Medicine of Jiangxi Key Laboratory The Second Affiliated Hospital of Nanchang University Nanchang Jiangxi 330006 China., Shuai WL; Department of Cardiovascular Medicine The 2nd Affiliated Hospital, Jiangxi Medical College, Nanchang University Nanchang Jiangxi China.; Molecular Medicine of Jiangxi Key Laboratory The Second Affiliated Hospital of Nanchang University Nanchang Jiangxi 330006 China., Zhang HC; Department of Cardiovascular Medicine The 2nd Affiliated Hospital, Jiangxi Medical College, Nanchang University Nanchang Jiangxi China.; Molecular Medicine of Jiangxi Key Laboratory The Second Affiliated Hospital of Nanchang University Nanchang Jiangxi 330006 China., Yang J; Department of Cardiovascular Medicine The 2nd Affiliated Hospital, Jiangxi Medical College, Nanchang University Nanchang Jiangxi China.; Molecular Medicine of Jiangxi Key Laboratory The Second Affiliated Hospital of Nanchang University Nanchang Jiangxi 330006 China., Xiong HL; Department of Cardiovascular Medicine The 2nd Affiliated Hospital, Jiangxi Medical College, Nanchang University Nanchang Jiangxi China.; Molecular Medicine of Jiangxi Key Laboratory The Second Affiliated Hospital of Nanchang University Nanchang Jiangxi 330006 China., Dong YF; Department of Cardiovascular Medicine The 2nd Affiliated Hospital, Jiangxi Medical College, Nanchang University Nanchang Jiangxi China.; Molecular Medicine of Jiangxi Key Laboratory The Second Affiliated Hospital of Nanchang University Nanchang Jiangxi 330006 China.

Source: Journal of the American Heart Association [J Am Heart Assoc] 2026 Oct 06; Vol. 15 (19), pp. e049591. Date of Electronic Publication: 2026 Sep 24.

Publication Type: Journal Article; Observational Study

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2047-9980 (Electronic) Linking ISSN: 20479980 NLM ISO Abbreviation: J Am Heart Assoc Subsets: MEDLINE

MeSH Terms: Hyperaldosteronism*/blood , Hyperaldosteronism*/diagnosis , Hyperaldosteronism*/epidemiology , Hyperaldosteronism*/diagnostic imaging , Dexamethasone*/administration & dosage , Hydrocortisone*/blood , Adrenal Glands*/diagnostic imaging , Glucocorticoids*/administration & dosage , Tomography, X-Ray Computed*, Biomarkers/blood ; Hypertension/etiology ; Hypertension/diagnosis ; Humans ; Female ; Male ; Middle Aged ; Prospective Studies ; Propensity Score ; Risk Factors ; Predictive Value of Tests ; Prevalence ; Logistic Models ; Aged ; Multivariate Analysis ; Adrenal Cortex Function Tests

Diagnostic concordance of CXCR4-PET/CT and adrenal vein sampling in subtyping primary aldosteronism and its guiding value for percutaneous adrenal artery embolisation: a prospective diagnostic test accuracy study protocol.

Authors: Chen S; Department of Cardiology, Lanzhou University Second Hospital, Lanzhou, Gansu, China., Yu H; Department of Cardiology, Lanzhou University Second Hospital, Lanzhou, Gansu, China., Liang W; Department of Cardiology, Lanzhou University Second Hospital, Lanzhou, Gansu, China., Li C; Department of Cardiology, Lanzhou University Second Hospital, Lanzhou, Gansu, China., Ma R; Department of Cardiology, Lanzhou University Second Hospital, Lanzhou, Gansu, China., Zhang X; Department of Cardiology, Lanzhou University Second Hospital, Lanzhou, Gansu, China., Sun R; Department of Cardiology, Lanzhou University Second Hospital, Lanzhou, Gansu, China., Zhao X; Department of Cardiology, Lanzhou University Second Hospital, Lanzhou, Gansu, China., Huang L; Department of Nuclear Medicine, Lanzhou University Second Hospital, Lanzhou, Gansu, China., Wu X; Department of Urology, Lanzhou University Second Hospital, Lanzhou, Gansu, China., Du F; Department of Cardiology, Lanzhou University Second Hospital, Lanzhou, Gansu, China., Wang Q; Department of Cardiology, Lanzhou University Second Hospital, Lanzhou, Gansu, China wqyconnie@163.com.

Source: BMJ open [BMJ Open] 2026 Oct 05; Vol. 16 (10), pp. e124662. Date of Electronic Publication: 2026 Oct 05.

Publication Type: Journal Article

Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE

MeSH Terms: Hyperaldosteronism*/therapy , Hyperaldosteronism*/diagnostic imaging , Hyperaldosteronism*/diagnosis , Adrenal Glands*/blood supply , Adrenal Glands*/diagnostic imaging , Positron Emission Tomography Computed Tomography*/methods , Receptors, CXCR4*/metabolism , Embolization, Therapeutic*/methods, Aldosterone/blood ; Humans ; Prospective Studies ; Female ; Veins ; Adult ; Male

Surgical decision-making and referral patterns for adrenal vein sampling in primary aldosteronism: a national survey of endocrine surgeons.

Authors: Neff M; University of Miami Leonard M. Miller School of Medicine, Miami, FL, United States., Kozlowski K; University of Miami Leonard M. Miller School of Medicine, Miami, FL, United States., Issa C; University of Miami Leonard M. Miller School of Medicine, Miami, FL, United States., Patel A; University of Miami Leonard M. Miller School of Medicine, Miami, FL, United States., Lin J; University of Miami Leonard M. Miller School of Medicine, Miami, FL, United States., Clode H; University of Miami Leonard M. Miller School of Medicine, Miami, FL, United States., Pennix T; University of Miami Leonard M. Miller School of Medicine, Miami, FL, United States., Hannoush Z; Division of Endocrinology, Diabetes and Metabolism, University of Miami Health, Miami, FL, United States., Ayala A; Division of Endocrinology, Diabetes and Metabolism, University of Miami Health, Miami, FL, United States., Lew JI; University of Miami Leonard M. Miller School of Medicine, Miami, FL, United States.; Division of Endocrine Surgery, DeWitt Daughtry Family Department of Surgery, University of Miami Health, Miami, FL, United States., Miller ZA; University of Miami Leonard M. Miller School of Medicine, Miami, FL, United States.; Department of Interventional Radiology, University of Miami Health System/Jackson Memorial Hospital, Miami, FL, United States.

Source: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2026 Oct 01; Vol. 17, pp. 1909164. Date of Electronic Publication: 2026 Oct 01 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE

MeSH Terms: Hyperaldosteronism*/surgery , Hyperaldosteronism*/diagnosis , Hyperaldosteronism*/blood , Referral and Consultation*/statistics & numerical data , Adrenal Glands*/blood supply , Adrenal Glands*/surgery , Practice Patterns, Physicians'*/statistics & numerical data , Clinical Decision-Making* , Surgeons*, Humans ; Cross-Sectional Studies ; Surveys and Questionnaires ; Female ; Veins ; Male ; Radiology, Interventional

Inverse association between the extracellular matrix protein Tenascin-X and concurrent abdominal aortic calcification in patients with primary aldosteronism.

Authors: Zhang R; Hypertension Center of People's Hospital of Xinjiang Uygur Autonomous Region, Xinjiang Hypertension Institute, National Health Committee Key Laboratory of Hypertension Clinical Research Key Laboratory of Xinjiang Uygur Autonomous Region, Hypertension Research Laboratory, Xinjiang Clinical Medical Research Center for Hypertension (Cardio-Cerebrovascular) Diseases, Urumqi, China., Aila M; Hypertension Center of People's Hospital of Xinjiang Uygur Autonomous Region, Xinjiang Hypertension Institute, National Health Committee Key Laboratory of Hypertension Clinical Research Key Laboratory of Xinjiang Uygur Autonomous Region, Hypertension Research Laboratory, Xinjiang Clinical Medical Research Center for Hypertension (Cardio-Cerebrovascular) Diseases, Urumqi, China., Zhu Q; Hypertension Center of People's Hospital of Xinjiang Uygur Autonomous Region, Xinjiang Hypertension Institute, National Health Committee Key Laboratory of Hypertension Clinical Research Key Laboratory of Xinjiang Uygur Autonomous Region, Hypertension Research Laboratory, Xinjiang Clinical Medical Research Center for Hypertension (Cardio-Cerebrovascular) Diseases, Urumqi, China., Saiding S; Hypertension Center of People's Hospital of Xinjiang Uygur Autonomous Region, Xinjiang Hypertension Institute, National Health Committee Key Laboratory of Hypertension Clinical Research Key Laboratory of Xinjiang Uygur Autonomous Region, Hypertension Research Laboratory, Xinjiang Clinical Medical Research Center for Hypertension (Cardio-Cerebrovascular) Diseases, Urumqi, China., Wang M; Hypertension Center of People's Hospital of Xinjiang Uygur Autonomous Region, Xinjiang Hypertension Institute, National Health Committee Key Laboratory of Hypertension Clinical Research Key Laboratory of Xinjiang Uygur Autonomous Region, Hypertension Research Laboratory, Xinjiang Clinical Medical Research Center for Hypertension (Cardio-Cerebrovascular) Diseases, Urumqi, China., Wu T; Hypertension Center of People's Hospital of Xinjiang Uygur Autonomous Region, Xinjiang Hypertension Institute, National Health Committee Key Laboratory of Hypertension Clinical Research Key Laboratory of Xinjiang Uygur Autonomous Region, Hypertension Research Laboratory, Xinjiang Clinical Medical Research Center for Hypertension (Cardio-Cerebrovascular) Diseases, Urumqi, China., Guo B; Hypertension Center of People's Hospital of Xinjiang Uygur Autonomous Region, Xinjiang Hypertension Institute, National Health Committee Key Laboratory of Hypertension Clinical Research Key Laboratory of Xinjiang Uygur Autonomous Region, Hypertension Research Laboratory, Xinjiang Clinical Medical Research Center for Hypertension (Cardio-Cerebrovascular) Diseases, Urumqi, China., Li N; Hypertension Center of People's Hospital of Xinjiang Uygur Autonomous Region, Xinjiang Hypertension Institute, National Health Committee Key Laboratory of Hypertension Clinical Research Key Laboratory of Xinjiang Uygur Autonomous Region, Hypertension Research Laboratory, Xinjiang Clinical Medical Research Center for Hypertension (Cardio-Cerebrovascular) Diseases, Urumqi, China., Luo Q; Hypertension Center of People's Hospital of Xinjiang Uygur Autonomous Region, Xinjiang Hypertension Institute, National Health Committee Key Laboratory of Hypertension Clinical Research Key Laboratory of Xinjiang Uygur Autonomous Region, Hypertension Research Laboratory, Xinjiang Clinical Medical Research Center for Hypertension (Cardio-Cerebrovascular) Diseases, Urumqi, China.

Source: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2026 Oct 01; Vol. 17, pp. 1900237. Date of Electronic Publication: 2026 Oct 01 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE

MeSH Terms: Tenascin*/blood , Tenascin*/metabolism , Hyperaldosteronism*/complications , Hyperaldosteronism*/blood , Hyperaldosteronism*/metabolism , Hyperaldosteronism*/pathology , Aorta, Abdominal*/pathology , Aorta, Abdominal*/metabolism , Vascular Calcification*/blood , Vascular Calcification*/metabolism , Vascular Calcification*/pathology , Vascular Calcification*/etiology, Extracellular Matrix Proteins/metabolism ; Muscle, Smooth, Vascular/metabolism ; Biomarkers/blood ; Humans ; Animals ; Male ; Female ; Mice ; Middle Aged ; Proteomics ; Mice, Inbred C57BL

Aldosterone synthase inhibitors may alter how primary care treats hypertension.

Authors: Lin PJ; Canadian Heart Research Centre, 398 Steeles Avenue West, Units #11-14, Thornhill, Ontario, L4J 6X3, Canada.

Source: American journal of hypertension [Am J Hypertens] 2026 Oct 01; Vol. 39 (Supplement_1), pp. S43-S48.

Publication Type: Journal Article; Review

Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 8803676 Publication Model: Print Cited Medium: Internet ISSN: 1941-7225 (Electronic) Linking ISSN: 08957061 NLM ISO Abbreviation: Am J Hypertens Subsets: MEDLINE

MeSH Terms: Hypertension*/drug therapy , Hypertension*/physiopathology , Hypertension*/diagnosis , Cytochrome P-450 CYP11B2*/antagonists & inhibitors , Cytochrome P-450 CYP11B2*/metabolism , Hyperaldosteronism*/drug therapy , Hyperaldosteronism*/diagnosis , Antihypertensive Agents*/therapeutic use , Blood Pressure*/drug effects , Enzyme Inhibitors*/therapeutic use , Primary Health Care*, Aldosterone/blood ; Mineralocorticoid Receptor Antagonists/therapeutic use ; Humans ; Treatment Outcome

From low renin to the primary aldosteronism spectrum: aldosterone synthase inhibitors and the endocrine management of hypertension.

Authors: Kline GA; Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Source: American journal of hypertension [Am J Hypertens] 2026 Oct 01; Vol. 39 (Supplement_1), pp. S66-S77.

Publication Type: Journal Article; Review

Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 8803676 Publication Model: Print Cited Medium: Internet ISSN: 1941-7225 (Electronic) Linking ISSN: 08957061 NLM ISO Abbreviation: Am J Hypertens Subsets: MEDLINE

MeSH Terms: Hyperaldosteronism*/drug therapy , Hyperaldosteronism*/blood , Hyperaldosteronism*/physiopathology , Hyperaldosteronism*/diagnosis , Hyperaldosteronism*/complications , Hypertension*/drug therapy , Hypertension*/physiopathology , Hypertension*/etiology , Hypertension*/blood , Cytochrome P-450 CYP11B2*/antagonists & inhibitors , Cytochrome P-450 CYP11B2*/metabolism , Renin*/blood , Antihypertensive Agents*/therapeutic use , Antihypertensive Agents*/adverse effects , Blood Pressure*/drug effects , Enzyme Inhibitors*/therapeutic use, Mineralocorticoid Receptor Antagonists/therapeutic use ; Aldosterone/blood ; Renin-Angiotensin System/drug effects ; Humans ; Treatment Outcome ; Animals

Pathophysiology of aldosterone dysregulation in difficult-to-control hypertension.

Authors: Borghi C; Department of Cardiovascular Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Fogacci F; Department of Cardiovascular Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Cicero AFG; Department of Cardiovascular Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Source: American journal of hypertension [Am J Hypertens] 2026 Oct 01; Vol. 39 (Supplement_1), pp. S11-S17.

Publication Type: Journal Article; Review

Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 8803676 Publication Model: Print Cited Medium: Internet ISSN: 1941-7225 (Electronic) Linking ISSN: 08957061 NLM ISO Abbreviation: Am J Hypertens Subsets: MEDLINE

MeSH Terms: Aldosterone*/metabolism , Aldosterone*/blood , Hypertension*/physiopathology , Hypertension*/drug therapy , Hypertension*/etiology , Hypertension*/metabolism , Renin-Angiotensin System*/drug effects , Renin-Angiotensin System*/physiology , Hyperaldosteronism*/physiopathology , Hyperaldosteronism*/complications , Blood Pressure*/drug effects , Hypoaldosteronism*/physiopathology , Hypoaldosteronism*/complications, Receptors, Mineralocorticoid/metabolism ; Antihypertensive Agents/therapeutic use ; Humans ; Animals ; Risk Factors

Inappropriately normal aldosterone levels as the norm for hyperaldosteronism: Use of a modified aldosterone-to-renin ratio to enhance primary aldosteronism detection.

Authors: Bauzon J; Center for Endocrine Surgery, Integrated Surgical Institute, Cleveland Clinic, Cleveland, OH., Romero-Velez G; Center for Endocrine Surgery, Integrated Surgical Institute, Cleveland Clinic, Cleveland, OH; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University School of Medicine, Cleveland, OH., Perez-Soto R; Center for Endocrine Surgery, Integrated Surgical Institute, Cleveland Clinic, Cleveland, OH., Berber E; Center for Endocrine Surgery, Integrated Surgical Institute, Cleveland Clinic, Cleveland, OH; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University School of Medicine, Cleveland, OH., Siperstein A; Center for Endocrine Surgery, Integrated Surgical Institute, Cleveland Clinic, Cleveland, OH; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University School of Medicine, Cleveland, OH. Electronic address: sipersa@ccf.org.

Source: Surgery [Surgery] 2026 Oct; Vol. 198, pp. 110473. Date of Electronic Publication: 2026 Jul 22.

Publication Type: Journal Article

Journal Info: Publisher: Mosby Country of Publication: United States NLM ID: 0417347 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-7361 (Electronic) Linking ISSN: 00396060 NLM ISO Abbreviation: Surgery Subsets: MEDLINE

MeSH Terms: Hyperaldosteronism*/diagnosis , Hyperaldosteronism*/blood , Renin*/blood , Aldosterone*/blood , Adrenal Gland Neoplasms*/blood , Adrenal Gland Neoplasms*/diagnosis, Humans ; Female ; Middle Aged ; Retrospective Studies ; Male ; ROC Curve ; Adult ; Sensitivity and Specificity ; Aged

CT-based body composition enhances prognostic performance of PASO score for surgical outcome in primary aldosteronism.

Authors: Lee S; Department of Internal Medicine, Severance Hospital, Endocrine Research Institute, Yonsei University College of Medicine, Seoul, Korea., Cho SJ; Division of Endocrinology and Metabolism, Department of Internal Medicine, International St. Mary's Hospital, Catholic Kwandong University College of Medicine, Incheon, Korea., Park JA; Department of Internal Medicine, Severance Hospital, Endocrine Research Institute, Yonsei University College of Medicine, Seoul, Korea., Baek S; Department of Internal Medicine, Severance Hospital, Endocrine Research Institute, Yonsei University College of Medicine, Seoul, Korea., Rhee Y; Department of Internal Medicine, Severance Hospital, Endocrine Research Institute, Yonsei University College of Medicine, Seoul, Korea., Hong N; Department of Internal Medicine, Severance Hospital, Endocrine Research Institute, Yonsei University College of Medicine, Seoul, Korea. nkhong84@yuhs.ac.

Source: Hypertension research : official journal of the Japanese Society of Hypertension [Hypertens Res] 2026 Oct; Vol. 49 (10), pp. 2854-2863. Date of Electronic Publication: 2026 Aug 06.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9307690 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1348-4214 (Electronic) Linking ISSN: 09169636 NLM ISO Abbreviation: Hypertens Res Subsets: MEDLINE

MeSH Terms: Hyperaldosteronism*/surgery , Hyperaldosteronism*/diagnostic imaging , Body Composition*, Humans ; Female ; Tomography, X-Ray Computed ; Male ; Middle Aged ; Prognosis ; Adrenalectomy ; Treatment Outcome ; Adult ; Retrospective Studies ; Body Mass Index

Prevalence and cardiometabolic impact of mild autonomous cortisol secretion in primary aldosteronism: a systematic review and meta-analysis.

Authors: Eisa N; Community Health Partners, Fresno, California, USA., Khoury M; Faculty of Medicine, Damascus University, Damascus, Syria.

Source: Journal of hypertension [J Hypertens] 2026 Oct 01; Vol. 44 (10), pp. 1667-1676. Date of Electronic Publication: 2026 Jul 16.

Publication Type: Journal Article; Systematic Review; Meta-Analysis

Journal Info: Publisher: Wolters Kluwer Health, Inc Country of Publication: Netherlands NLM ID: 8306882 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-5598 (Electronic) Linking ISSN: 02636352 NLM ISO Abbreviation: J Hypertens Subsets: MEDLINE

MeSH Terms: Hyperaldosteronism*/epidemiology , Hyperaldosteronism*/blood , Hyperaldosteronism*/complications , Hyperaldosteronism*/metabolism , Hydrocortisone*/metabolism , Hydrocortisone*/blood , Cardiovascular Diseases*/epidemiology, Diabetes Mellitus, Type 2/epidemiology ; Humans ; Prevalence

Clinical phenotypes and disease outcomes of patients with systemic lupus erythematosus meeting indication for primary aldosteronism testing.

Authors: Wong M; Department of Medicine, Monash University, Clayton, VIC, Australia., Akram M; Centre for Endocrinology and Reproductive Health, Hudson Institute of Medical Research, Clayton, VIC, Australia., Kent JR; Department of Nephrology, Monash Health, Clayton, VIC, Australia., Fuller PJ; Centre for Endocrinology and Reproductive Health, Hudson Institute of Medical Research, Clayton, VIC, Australia.; Department of Endocrinology, Monash Health, Clayton, VIC, Australia., Hoi AY; Department of Rheumatology, Monash Health, Clayton, VIC, Australia.; Centre for Inflammatory Diseases, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia., Yang J; Department of Medicine, Monash University, Clayton, VIC, Australia.; Centre for Endocrinology and Reproductive Health, Hudson Institute of Medical Research, Clayton, VIC, Australia.; Department of Endocrinology, Monash Health, Clayton, VIC, Australia., Vincent FB; Centre for Inflammatory Diseases, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia.

Source: Lupus [Lupus] 2026 Oct; Vol. 35 (12), pp. 1308-1319. Date of Electronic Publication: 2026 Jul 31.

Publication Type: Journal Article

Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9204265 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0962 (Electronic) Linking ISSN: 09612033 NLM ISO Abbreviation: Lupus Subsets: MEDLINE

MeSH Terms: Hyperaldosteronism*/diagnosis , Hyperaldosteronism*/complications , Hyperaldosteronism*/epidemiology , Lupus Erythematosus, Systemic*/complications , Lupus Erythematosus, Systemic*/physiopathology , Hypertension*/etiology , Hypertension*/epidemiology , Hypertension*/diagnosis, Humans ; Female ; Retrospective Studies ; Phenotype ; Middle Aged ; Male ; Adult ; Blood Pressure ; Prevalence